Concepedia

Efficacy and safety of ripretinib vs. sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib: A phase 2, multicenter, randomized, open-label study in China

Jian Li, Jun Zhang, Yanqiao Zhang, Haibo Qiu, Yanbing Zhou, Yongjian Zhou, Xinhua Zhang, Ye Zhou, Yuping Zhu, Yong Li,

European Journal of Cancer · 2023 · 12 citations · 20 references

DOI

Concepts

References

20

The National Comprehensive Cancer Network

William T. McGivney · Cancer · 1998 · 16.9K citations

, , +15

Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial

George D. Demetri, Allan T. van Oosterom, Christopher R. Garrett et al. · The Lancet · 2006 · 2.6K citations

, , +8

Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial

George D. Demetri, Peter Reichardt, Yoon‐Koo Kang et al. · The Lancet · 2012 · 1.4K citations · Full text

, , +8

Molecular Correlates of Imatinib Resistance in Gastrointestinal Stromal Tumors

Michael C. Heinrich, Christopher L. Corless, Charles D. Blanke et al. · Journal of Clinical Oncology · 2006 · 814 citations

, , +17

Primary and Secondary Kinase Genotypes Correlate With the Biological and Clinical Activity of Sunitinib in Imatinib-Resistant Gastrointestinal Stromal Tumor

Michael C. Heinrich, Robert G. Maki, Christopher L. Corless et al. · Journal of Clinical Oncology · 2008 · 806 citations · Full text

, , +17